Garwood Medical Devices
Garwood Medical Devices is a medical technology company dedicated to changing outcomes for patients with implant biofilm infections. They focus on advancing innovative technologies, including their BioPrax™ device, to improve treatment effectiveness and work alongside existing standards of care. Their mission includes helping patients retain implants and reducing the economic burden of prosthetic joint infections. The company has received FDA Breakthrough Device Designation and has garnered global attention through partnerships and awards, including being a winner of the Johnson & Johnson QuickFire Challenge and being nominated in MedTech Innovator’s $10,000 Best Video Competition.
Industries
Nr. of Employees
small (1-50)
Garwood Medical Devices
Buffalo, New York, United States, North America
Products
Implant-targeted electrochemical anti-biofilm device
A minimally invasive clinical device that delivers low-voltage energy through an implant via a percutaneous electrode to create an electrochemical reaction that eliminates bacterial biofilms on metallic implant surfaces; intended for use during early intervention alongside washout and debridement.
Implant-targeted electrochemical anti-biofilm device
A minimally invasive clinical device that delivers low-voltage energy through an implant via a percutaneous electrode to create an electrochemical reaction that eliminates bacterial biofilms on metallic implant surfaces; intended for use during early intervention alongside washout and debridement.
Services
Device demonstrations and clinical outreach
On-demand demonstrations of the electrical stimulation treatment device for clinicians and potential partners; informational engagement for investors and stakeholders.
Collaborative preclinical research partnerships
Collaborative R&D with academic and industry partners to perform laboratory and animal studies validating platform efficacy and development.
Device demonstrations and clinical outreach
On-demand demonstrations of the electrical stimulation treatment device for clinicians and potential partners; informational engagement for investors and stakeholders.
Collaborative preclinical research partnerships
Collaborative R&D with academic and industry partners to perform laboratory and animal studies validating platform efficacy and development.
Expertise Areas
- Implant-associated biofilm treatment
- Electrochemical anti-biofilm methods
- Preclinical in vitro and in vivo testing
- Medical device regulatory interactions (FDA Breakthrough Device pathway)
Key Technologies
- Low-voltage electrochemical biofilm disruption
- Percutaneous electrode delivery
- Implant-surface electrical stimulation
- Touchscreen clinical device interface